抗菌肽Cec4抑制临床耐碳青霉烯类鲍曼不动杆菌生物被膜的机制研究

批准号:
82002180
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
彭建
依托单位:
学科分类:
医院获得性感染
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
彭建
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
被称为“超级细菌”的鲍曼不动杆菌,极易对碳青霉烯类抗生素耐药。研究证实生物被膜态的细菌,有更强的耐药性和体外存活能力。细菌的双组份系统、群体感应(Quorum sensing,QS)及菌毛生成与其生物被膜的形成密切相关。本项目前期研究发现,抗菌肽Cec4,体内外毒性低,不仅对游离鲍曼不动杆菌有较好的杀菌效果,亦能抑制耐药菌生物被膜的形成,但目前抗菌肽如何抑制及清除细菌生物被膜的潜在机制尚不清楚。因此,通过从200株临床菌株中,筛选出生物被膜形成能力强的菌株;通过转录组和蛋白组关联分析,比较抗菌肽Cec4作用前后生物被膜态耐药菌形成生物被膜相关基因表达的差异,并鉴定与Cec4直接相互作用的蛋白,以期发现Cec4抑制生物被膜态耐药菌的关键分子及信号通路;通过对候选基因的敲出及回补实验,开展生物被膜表型及功能研究,证实Cec4抑制耐药菌生物被膜的潜在机制,最终为抗菌肽的药物研发提供理论支持。
英文摘要
It is well known that Acinetobacter baumannii is referred to as "super bacteria" with tending to carbapenem antibiotics resistance, and the bacteria in the biofilm state have stronger drug resistance and survivability in vitro. The bacterial two-component system, quorum sensing (QS) and fimbriae formation are closely related to the formation of its biofilm. The preliminary study of this project found that the antibacterial peptide Cec4 has low toxicity in vivo and in vivo. It not only has a good bactericidal effect on planktonic Acinetobacter baumannii, but also can inhibit the formation of its biofilm. However, the underlying mechanism of how antimicrobial peptides inhibit and remove bacterial biofilms is unclear. Therefore, strains with strong biofilm formation ability were screened from 200 clinical strains. Through transcriptome and proteomic correlation analysis, the differences in the expression of genes related to biofilm formation in biofilm resistant bacteria before and after the treatment of Cec4 were compared, and the proteins directly interacting with Cec4 will be identified, in order to discover the key molecules and signaling pathways of Cec4 inhibiting the biofilm formation of biofilm resistant bacteria. The phenotype and function of the biofilm will be studied by knocking out and supplementing the candidate genes, and the potential mechanism of Cec4 inhibiting the biofilm of drug-resistant bacteria will be confirmed, finally providing theoretical support for the drug development of antimicrobial peptides.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1128/spectrum.02409-22
发表时间:2022-12-21
期刊:Microbiology spectrum
影响因子:3.7
作者:
通讯作者:
DOI:10.2147/dddt.s405579
发表时间:2023
期刊:DRUG DESIGN DEVELOPMENT AND THERAPY
影响因子:4.8
作者:Peng, Jian;Wang, Yue;Wu, Zhaoyin;Mao, Chengju;Li, Lu;Cao, Huijun;Qiu, Zhilang;Guo, Guo;Liang, Guiyou;Shen, Feng
通讯作者:Shen, Feng
DOI:10.13523/j.cb.2105046
发表时间:2021
期刊:中国生物工程杂志
影响因子:--
作者:陈素芳;夏明印;曾丽艳;安晓琴;田敏芳;彭建
通讯作者:彭建
Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus.
新型天蚕素 4 衍生肽对抗耐甲氧西林金黄色葡萄球菌
DOI:10.3390/antibiotics10010036
发表时间:2021-01-01
期刊:Antibiotics (Basel, Switzerland)
影响因子:--
作者:Peng J;Mishra B;Khader R;Felix L;Mylonakis E
通讯作者:Mylonakis E
DOI:10.1016/j.dci.2023.105111
发表时间:2023-12-21
期刊:DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
影响因子:2.9
作者:Peng,Jian;Li,Lu;Liang,Guiyou
通讯作者:Liang,Guiyou
家蝇天蚕素Cec4及其衍生肽抑制鲍曼不动杆菌的作用与机制研究
- 批准号:81660347
- 项目类别:地区科学基金项目
- 资助金额:38.0万元
- 批准年份:2016
- 负责人:彭建
- 依托单位:
国内基金
海外基金
